ATRA Atara Biotherapeutics Inc

Atara Biotherapeutics Inc is engaged in the development of pharmaceutical products. Its focus lies on developing therapies addressing serious-life threatening diseases in the United States.

$2.88  +0.02 (0.52%)
As of 03/24/2023 15:59:58 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/16/2014
Outstanding shares:  95,926,711
Average volume:  1,290,185
Market cap:   $275,309,661
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BP4WT09

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%